# MIRAGE Study: Clinical Outcomes of the Mamba Sirolimus-Eluting PTCA Balloon

Study · id `cardio:ct-nct07326735` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07326735](<https://clinicaltrials.gov/study/NCT07326735>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07326735

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 360 participants.

## Technical summary

Registry record NCT07326735. Allocation not applicable; no masking; primary purpose treatment. Start 2023-01-11 (actual); primary completion 2024-01-22 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 360 participants (enrolled count; ClinicalTrials.gov record NCT07326735, source copy `cardio:ctgov-nct07326735-2026-03-11`, retrieved 2026-10-26)
- Started: 2023-01-11 (actual) (ClinicalTrials.gov record NCT07326735, source copy `cardio:ctgov-nct07326735-2026-03-11`, retrieved 2026-10-26)
- Primary completion: 2024-01-22 (actual) (ClinicalTrials.gov record NCT07326735, source copy `cardio:ctgov-nct07326735-2026-03-11`, retrieved 2026-10-26)
- Completion: 2024-03-03 (actual) (ClinicalTrials.gov record NCT07326735, source copy `cardio:ctgov-nct07326735-2026-03-11`, retrieved 2026-10-26)
- Countries: Myanmar (Burma); Malaysia (ClinicalTrials.gov record NCT07326735, source copy `cardio:ctgov-nct07326735-2026-03-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07326735-2026-03-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: MIRAGE Study: Clinical Outcomes of the Mamba Sirolimus-Eluting PTCA Balloon
- Condition: Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
- Intervention (Device): Mamba Sirolimus-Eluting PTCA Balloon
- Intervention (Device): Percutaneous Coronary Angioplasty with Sirolimus-Coated Balloon
- Lead sponsor: Frisch Medical Device Private Limited
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)

## Provenance

Content hash: bd6bff2c371c465177a3e9543a3fbdf23d89aec382d9a94f523dbc472fffa1a8
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
